Quest Diagnostics Reports Q3 Results and Raises 2026 Guidance
Quest Diagnostics reported adjusted EPS of $3.00 and revenue of $3.10 billion, above FactSet estimates of $2.87 and $3.05 billion, respectively. It raised its 2026 revenue guidance to $12.07 billion-$12.11 billion and adjusted EPS guidance to $11.25-$11.35.
Quest Diagnostics Incorporated posted adjusted earnings per share of $3.00 for the third quarter of 2026, above the FactSet consensus estimate of $2.87. Revenue was $3.10 billion, compared with expectations of $3.05 billion. The company raised its full-year 2026 revenue forecast to a range of $12.07 billion to $12.11 billion, from its prior estimate of $12.02 billion. It also lifted its full-year 2026 adjusted earnings-per-share guidance to $11.25 to $11.35, versus the previous estimate of $11.20.